tm logo
ZYRTALK
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 21 Dec 2023

Last Applicant/ Owned by

Allée de la Recherche 60

Brussels

BE

B-1070

Serial Number

97835527 filed on 13th Mar 2023

Registration Number

N/A

Correspondent Address

Kumiko Ide

WENDEROTH, LIND & PONACK, L.L.P.

1025 CONNECTICUT AVENUE NW, SUITE 500

WASHINGTON,DC 20036

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZYRTALK

providing information in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies educational and entertainment services, namely, a series of videos in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies accessible via computer networks, web-based applications, and mobile phone applications

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


providing information in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies

Class [041]
Education and Entertainment Services


educational and entertainment services, namely, a series of videos in the field of antihistamine and decongestant preparations, and the treatment and diagnosis of allergies accessible via computer networks, web-based applications, and mobile phone applications

Mark Details


Serial Number

No 97835527

Mark Type

No Service Mark

Attorney Docket Number

No TM23-0097

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Mar 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
20th Mar 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
21st Dec 2023NON-FINAL ACTION WRITTEN
21st Dec 2023NON-FINAL ACTION E-MAILED
21st Dec 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
19th Dec 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
19th Dec 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
19th Dec 2023TEAS/EMAIL CORRESPONDENCE ENTERED
02th Nov 2023NON-FINAL ACTION WRITTEN
02th Nov 2023NON-FINAL ACTION E-MAILED